A recent GWAS reported association of MMP20 with neovascular lesion size in age-related macular degeneration (AMD), suggesting a potential role for anti-vascular endothelial growth factors (anti-VEGFs) drugs in reversing the choroidal neovascularization (CNV) disease process17. This evidence concerns the gene MMP20 and choroidal neovascularization.